NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects United States. Department of Health and Human Services. Remove constraint Subjects: United States. Department of Health and Human Services. Publication Year 2020 Remove constraint Publication Year: <span class="single" data-blrl-single="2020">2020</span>

Search Results

31. Unique device identification: policy regarding compliance dates for class I and unclassified devices and certain devices requiring direct marking : immediately in effect guidance for industry and Food and Drug Administration staff

34. Institutional review board (IRB) review of individual patient expanded access requests for investigational drugs and biological products during the COVID-19 public health emergency: guidance for IRBs and clinical investigators

35. Temporary policy regarding preventive controls and FSVP food supplier verification onsite audit requirements during the COVID-19 public health emergency: guidance for industry

37. Patient-focused drug development: collecting comprehensive and representative input : guidance for industry, Food and Drug Administration staff, and other stakeholders

40. Hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia: developing drugs for treatment